Parecoxib Impurity 20 | CAS 37928-17-9 - Request Quote
Parecoxib Impurity 20
| SZ CAT No: | SZ-P047025 |
| CAS No | 37928-17-9 |
| Mol.F. | C16H13NO |
| Mol.Wt. | 235.3 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Parecoxib Impurity 20 is chemically 5-methyl-3,4-diphenylisoxazole. Parecoxib Impurity 20 is supplied with detailed characterization data compliant with regulatory guideline. Parecoxib Impurity 20 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Parecoxib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 37928-17-9
Purchase 37928-17-9
Order 37928-17-9
Enquire 37928-17-9
price of 37928-17-9
37928-17-9 Supplier
37928-17-9 Manufacturer
37928-17-9 Exporter
buy high quality Parecoxib Impurity 20
Purchase Parecoxib Impurity 20
Parecoxib Impurity 20 suppliers
Parecoxib Impurity 20 manufacturers
Parecoxib Impurity 20 price
Order Parecoxib Impurity 20
Enquire Parecoxib Impurity 20
Parecoxib Impurity 20 cost
Parecoxib Impurity 20 Supplier
Parecoxib Impurity 20 Distributor
Parecoxib Impurity 20 for Method Validation
Parecoxib Reference Standard
Parecoxib Impurity 20 for ANDA Filing
Parecoxib Impurity 20 for Forced Degradation Studies
Parecoxib Impurity 20 Identification Standards
Parecoxib Impurity 20 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


